# Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)

Study · id `cardio:ct-nct07717216` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07717216](<https://clinicaltrials.gov/study/NCT07717216>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07717216

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 314 participants.

## Technical summary

Registry record NCT07717216. Randomized; triple masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2029-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 314 participants (planned count; ClinicalTrials.gov record NCT07717216, source copy `cardio:ctgov-nct07717216-2026-07-21`, retrieved 2026-10-26)
- Planned start: 2026-09-01 (anticipated) (ClinicalTrials.gov record NCT07717216, source copy `cardio:ctgov-nct07717216-2026-07-21`, retrieved 2026-10-26)
- Primary completion: 2029-09-01 (anticipated) (ClinicalTrials.gov record NCT07717216, source copy `cardio:ctgov-nct07717216-2026-07-21`, retrieved 2026-10-26)
- Completion: 2029-09-01 (anticipated) (ClinicalTrials.gov record NCT07717216, source copy `cardio:ctgov-nct07717216-2026-07-21`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07717216-2026-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)
- Condition: Stroke, Acute
- Condition: Neuroprotection
- Condition: Normobaric Hyperoxia
- Condition: Endovascular Treatment
- Intervention (Drug): Oxygen (Normobaric Hyperoxia)
- Intervention (Drug): Sham Normobaric Hyperoxia
- Intervention (Procedure): Endovascular Therapy
- Lead sponsor: Weifang Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 886edbcbf653c01d7aac492bffd29646100a0a9931e4bc1e0cd117a159faf846
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
